Marie‐Françoise Bourgeade

1.8k total citations
46 papers, 1.5k citations indexed

About

Marie‐Françoise Bourgeade is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marie‐Françoise Bourgeade has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Immunology. Recurrent topics in Marie‐Françoise Bourgeade's work include interferon and immune responses (9 papers), TGF-β signaling in diseases (8 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Marie‐Françoise Bourgeade is often cited by papers focused on interferon and immune responses (9 papers), TGF-β signaling in diseases (8 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Marie‐Françoise Bourgeade collaborates with scholars based in France, Italy and United States. Marie‐Françoise Bourgeade's co-authors include Françoise Besançon, Azeddine Atfi, C Chany, E. Rogier, T. C. Merigan, Céline Prunier, Odile Devergne, Yvon E. Cayre, Jun‐ichiro Inoue and Anastassia Hatzoglou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Marie‐Françoise Bourgeade

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie‐Françoise Bourgeade France 23 722 474 379 231 209 46 1.5k
James R. Zucali United States 19 593 0.8× 447 0.9× 470 1.2× 259 1.1× 263 1.3× 42 1.5k
Masaki Ri Japan 24 1000 1.4× 446 0.9× 576 1.5× 461 2.0× 119 0.6× 117 1.9k
Toshihiko Ohtomo Japan 18 721 1.0× 419 0.9× 319 0.8× 86 0.4× 339 1.6× 31 1.5k
Vitaly A. Polunovsky United States 25 1.7k 2.4× 335 0.7× 306 0.8× 87 0.4× 301 1.4× 41 2.4k
J B Marriott United Kingdom 18 641 0.9× 348 0.7× 346 0.9× 610 2.6× 77 0.4× 26 1.3k
Thea Kalebic United States 21 727 1.0× 134 0.3× 424 1.1× 112 0.5× 238 1.1× 60 1.6k
Giovanni Abbadessa United States 24 732 1.0× 200 0.4× 582 1.5× 142 0.6× 170 0.8× 99 1.7k
Jean S. Beebe United States 19 636 0.9× 415 0.9× 314 0.8× 88 0.4× 142 0.7× 39 1.7k
Nandini Kishore United States 15 451 0.6× 690 1.5× 601 1.6× 258 1.1× 356 1.7× 20 1.9k
Koh Yamamoto Japan 14 629 0.9× 1.3k 2.7× 1.1k 2.8× 185 0.8× 175 0.8× 32 2.2k

Countries citing papers authored by Marie‐Françoise Bourgeade

Since Specialization
Citations

This map shows the geographic impact of Marie‐Françoise Bourgeade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Françoise Bourgeade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Françoise Bourgeade more than expected).

Fields of papers citing papers by Marie‐Françoise Bourgeade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Françoise Bourgeade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Françoise Bourgeade. The network helps show where Marie‐Françoise Bourgeade may publish in the future.

Co-authorship network of co-authors of Marie‐Françoise Bourgeade

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Françoise Bourgeade. A scholar is included among the top collaborators of Marie‐Françoise Bourgeade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Françoise Bourgeade. Marie‐Françoise Bourgeade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrigno, Olivier, Mingzhu Zhang, Mutsuko Ohnishi, et al.. (2013). Identification of PHRF1 as a Tumor Suppressor that Promotes the TGF-β Cytostatic Program through Selective Release of TGIF-Driven PML Inactivation. Cell Reports. 4(3). 530–541. 28 indexed citations
2.
Desterke, Christophe, Chrystèle Bilhou‐Nabera, Bernadette Guerton, et al.. (2011). FLT3-Mediated p38–MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis. Cancer Research. 71(8). 2901–2915. 35 indexed citations
3.
4.
Battaglia, Sérena, Nassima Benzoubir, Maria‐Rosa Ghigna, et al.. (2009). Transition épithélio-mésenchymateuse et carcinome hépatocellulaire. Annales de Pathologie. 29(5). S65–S66. 1 indexed citations
5.
Pozdzik, Agnieszka, Isabelle Salmon, Cécile Husson, et al.. (2008). Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrology Dialysis Transplantation. 23(8). 2480–2491. 67 indexed citations
6.
7.
Faresse, Nourdine, Frédéric Colland, Nathalie Ferrand, et al.. (2008). Identification of PCTA, a TGIF antagonist that promotes PML function in TGF‐β signalling. The EMBO Journal. 27(13). 1804–1815. 31 indexed citations
8.
Seo, Su Ryeon, Nathalie Ferrand, Nourdine Faresse, et al.. (2006). Nuclear Retention of the Tumor Suppressor cPML by the Homeodomain Protein TGIF Restricts TGF-β Signaling. Molecular Cell. 23(4). 547–559. 63 indexed citations
9.
Rogier, E., Antoine Dürrbach, Sophie Ferlicot, et al.. (2005). A novel biological assay to detect the active form of TGF-β in urine to monitor renal allograft rejection. Kidney International. 68(4). 1875–1883. 14 indexed citations
10.
Carvalho, Gabrielle, Didier Métivier, Alain Chapel, et al.. (2004). Chemosensitization by erythropoietin through inhibition of the NF-κB rescue pathway. Oncogene. 24(5). 737–745. 42 indexed citations
11.
Schrantz, Nicolas, et al.. (2001). Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos). Cell Death and Differentiation. 8(2). 152–161. 46 indexed citations
12.
Hatzoglou, Anastassia, Marie‐Françoise Bourgeade, E. Rogier, et al.. (2000). TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-κB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase. The Journal of Immunology. 165(3). 1322–1330. 208 indexed citations
13.
Atfi, Azeddine, Céline Prunier, Anne Mazars, et al.. (1999). The oncogenic TEL/PDGFRβ fusion protein induces cell death through JNK/SAPK pathway. Oncogene. 18(26). 3878–3885. 23 indexed citations
14.
Bourgeade, Marie‐Françoise, Christine Laurent‐Winter, Françoise Besançon, M.N. Thang, & Sylvie Mémet. (1993). Differential Kinetics of Polypeptide Expression and Different Biological Activities in the Human Fibroblast Response to dsRNA or Interferon Treatment. Journal of Interferon Research. 13(3). 175–186. 6 indexed citations
15.
Mémet, Sylvie, Françoise Besançon, & Marie‐Françoise Bourgeade. (1992). Simultaneous and quantitative isolation of nuclear and cytoplasmic RNA from eukaryotic cells. Trends in Genetics. 8(6). 190–190. 3 indexed citations
16.
Bourgeade, Marie‐Françoise, Flora Silbermann, Ugo Testa, et al.. (1992). Post-transcriptional regulation of transferrin receptor mRNA by IFNγ. Nucleic Acids Research. 20(12). 2997–3003. 21 indexed citations
17.
Mémet, Sylvie, Françoise Besançon, Marie‐Françoise Bourgeade, & Ming Nguy Thang. (1991). Direct Induction of Interferon-γ– and Interferon-α/β–Inducible Genes by Double-Stranded RNA. Journal of Interferon Research. 11(3). 131–141. 48 indexed citations
18.
Bourgeade, Marie‐Françoise, Flora Silbermann, M.N. Thang, & Françoise Besançon. (1988). Reduction of transferrin receptor expression by interferon γ in a human cell line sensitive to its antiproliferative effect. Biochemical and Biophysical Research Communications. 153(3). 897–903. 8 indexed citations
19.
Besançon, Françoise, Marie‐Françoise Bourgeade, & Ugo Testa. (1985). Inhibition of transferrin receptor expression by interferon-alpha in human lymphoblastoid cells and mitogen-induced lymphocytes.. Journal of Biological Chemistry. 260(24). 13074–13080. 32 indexed citations
20.
Bourgeade, Marie‐Françoise, S Rousset, D. Paulin, & C Chany. (1981). Reorganization of the Cytoskeleton by Interferon in MSV-Transformed Cells*. Journal of Interferon Research. 1(2). 323–332. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Zucali Breakdown of academic impact, for papers by Masaki Ri Breakdown of academic impact, for papers by Toshihiko Ohtomo Breakdown of academic impact, for papers by Vitaly A. Polunovsky Breakdown of academic impact, for papers by J B Marriott Breakdown of academic impact, for papers by Thea Kalebic Breakdown of academic impact, for papers by Giovanni Abbadessa Breakdown of academic impact, for papers by Jean S. Beebe Breakdown of academic impact, for papers by Nandini Kishore Breakdown of academic impact, for papers by Koh Yamamoto
Rankless by CCL
2026